Shypd.aiThe largest open index of AI toolsLeman Biotech is a Pharma & Biotech tool that develops innovative cancer immunotherapies. It integrates metabolic reprogramming technology with an AI drug discovery platform to create novel treatments.
Trending
Also listed in
About
Leman Biotech is a clinical-stage company specializing in the development of innovative cancer immunotherapies. Founded by a team from EPFL and XtalPi, the company leverages a unique combination of immune metabolic reprogramming and advanced artificial intelligence. Their core technologies include a metabolic reprogramming macromolecule platform (Meta 10) to reactivate exhausted T-cells, a metabolic-enhanced cell therapy platform, and an AI super-factor platform for efficient computational design of biomacromolecules. Leman Biotech focuses on researching, producing, and commercializing new oncology treatments, with recent successes including FDA IND approval for their META 10-19 injection and positive clinical trial results for their metabolic-enhanced CAR-T therapy.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check lemanbio.com for current pricing.
FAQs
Trending
